52 related articles for article (PubMed ID: 11075421)
1. [Trichoderma produces an inhibitor of the human immunodeficiency virus].
Smirnova IP; Alekseev SB; Moshkov DA
Vopr Med Khim; 2000; 46(4):384-7. PubMed ID: 11075421
[TBL] [Abstract][Full Text] [Related]
2. [Cytostatic effect of L-lysine-alpha-oxidase from Trichoderma harzianum Rifai and Trichoderma viride].
Khaduev SKh; Zhukova OS; Dobrynin IaV; Soda K; Berezov TT
Biull Eksp Biol Med; 1987 Apr; 103(4):458-60. PubMed ID: 3567343
[TBL] [Abstract][Full Text] [Related]
3. [Effect of L-lysine-alpha-oxidase on the synthesis of cell proteins, targets of autoimmune pathology in HIV infection].
Berezov TT; Zverev VV; Zaĭtsev IZ; Alekseev SB
Biull Eksp Biol Med; 1997 Jan; 123(1):36-8. PubMed ID: 9213453
[No Abstract] [Full Text] [Related]
4. [Comparative study of the effect of L-lysine-L-oxidase from Trichoderma harzianum Rifai and Trichoderma viride on nucleic acid synthesis in human tumor cells in vitro].
Khaduev SKh; Zhukova OS; Dobrynin IaV; Soda K; Berezov TT
Biull Eksp Biol Med; 1986 May; 101(5):603-4. PubMed ID: 3708146
[TBL] [Abstract][Full Text] [Related]
5. Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.
Jeeninga RE; Keulen W; Boucher C; Sanders RW; Berkhout B
Virology; 2001 May; 283(2):294-305. PubMed ID: 11336554
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.
Witvrouw M; Pannecouque C; Switzer WM; Folks TM; De Clercq E; Heneine W
Antivir Ther; 2004 Feb; 9(1):57-65. PubMed ID: 15040537
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial Activity of L-Lysine-α-Oxidase from the Trichoderma.
Smirnova IP; Karimova EV; Shneider YA
Bull Exp Biol Med; 2017 Oct; 163(6):777-779. PubMed ID: 29063340
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of zidovudine prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS.
Sriram D; Srichakravarthy N; Bal TR; Yogeeswari P
Biomed Pharmacother; 2005 Sep; 59(8):452-5. PubMed ID: 16154314
[TBL] [Abstract][Full Text] [Related]
9. Aryl nucleoside H-phosphonates. Part 15: Synthesis, properties and, anti-HIV activity of aryl nucleoside 5'-alpha-hydroxyphosphonates.
Szymańska A; Szymczak M; Boryski J; Stawiński J; Kraszewski A; Collu G; Sanna G; Giliberti G; Loddo R; La Colla P
Bioorg Med Chem; 2006 Mar; 14(6):1924-34. PubMed ID: 16290162
[TBL] [Abstract][Full Text] [Related]
10. [Screening of HIV-1 replication inhibitors by using pseudotyped virus system].
Cao YL; Guo Y
Yao Xue Xue Bao; 2008 Mar; 43(3):253-8. PubMed ID: 18630260
[TBL] [Abstract][Full Text] [Related]
11. Polysulfated sialic acid derivatives as anti-human immunodeficiency virus.
Terada M; Fujita S; Suda I; Mastico R
Biomed Pharmacother; 2005 Sep; 59(8):423-9. PubMed ID: 16143490
[TBL] [Abstract][Full Text] [Related]
12. L-Lysine-α-Oxidase: Acidovorax citrulli Bacterium Inhibitor.
Smirnova IP; Karimova EV; Shneider YA; Volina EG
Bull Exp Biol Med; 2018 Mar; 164(4):459-461. PubMed ID: 29504100
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells.
Hoever G; Groeschel B; Chandra P; Doerr HW; Cinatl J
Int J Mol Med; 2003 Jun; 11(6):743-7. PubMed ID: 12736716
[TBL] [Abstract][Full Text] [Related]
14. Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudine.
Turriziani O; Scagnolari C; Bambacioni F; Bellomi F; Focher F; Gentile M; Antonelli G
Antivir Ther; 2002 Jun; 7(2):105-11. PubMed ID: 12212922
[TBL] [Abstract][Full Text] [Related]
15. [L-Lysine-α-Oxidase in vitro Activity in Experiments on Models of Viruses Sindbis, Forest-Spring Encephalitis, Western Nile, Tyaginya and Dhori].
Smirnova IP; Larichev VF; Shneider YA
Antibiot Khimioter; 2015; 60(3-4):3-5. PubMed ID: 26415376
[TBL] [Abstract][Full Text] [Related]
16. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
17. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA.
Wu Y; Marsh JW
Science; 2001 Aug; 293(5534):1503-6. PubMed ID: 11520990
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of relationship between HIV infection and autoimmunity].
Smirnova IP; Alekseev SB; Berezov TT
Vopr Med Khim; 1996; 42(3):211-6. PubMed ID: 9139452
[TBL] [Abstract][Full Text] [Related]
19. Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
Gross E; Amella CA; Pompucci L; Franchin G; Sherry B; Schmidtmayerova H
J Leukoc Biol; 2003 Nov; 74(5):781-90. PubMed ID: 12960233
[TBL] [Abstract][Full Text] [Related]
20. Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76V.
Nijhuis M; Wensing AM; Bierman WF; de Jong D; Kagan R; Fun A; Jaspers CA; Schurink KA; van Agtmael MA; Boucher CA
J Infect Dis; 2009 Sep; 200(5):698-709. PubMed ID: 19627247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
